Manonthestreet
Diamond Member
- May 20, 2014
- 34,728
- 23,005
- 1,945
The findings from 146 people – of whom half took 800 micrograms of the medication twice a day and half were on usual care – suggests that inhaled budesonide reduced the relative risk of requiring urgent care or hospitalisation by 90% in the 28-day study period. Participants allocated the budesonide inhaler also had a quicker resolution of fever, symptoms and fewer persistent symptoms after 28 days. Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests | University of Oxford
Why did it take so long for this to be recognized? We have a disease that makes it hard to breath, lets see what do we have that might make it easier to breath, I know a ventilator. So sad, meanwhile experimental "vaccine" is the go to solution.
Why did it take so long for this to be recognized? We have a disease that makes it hard to breath, lets see what do we have that might make it easier to breath, I know a ventilator. So sad, meanwhile experimental "vaccine" is the go to solution.